Drug Approval | March 28, 2024
Briefs: Alkem Laboratories and Zydus Lifesciences
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The company has received Form 483 with three observations
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023
He holds a Bachelor’s Degree in Science and has joined the company in 2012 and has over 10 years of experience in pharmaceutical industry
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)